HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Electrochemotherapy as a novel treatment for primary cutaneous marginal zone B-cell lymphomas.

Abstract
In the present study, we describe the use of electrochemotherapy as alternative therapy for primary cutaneous marginal zone B-cell lymphomas in patients unsuitable for surgery or radiotherapy. Our experience refers to three patients with primary cutaneous marginal zone B-cell lymphomas related to Borrelia burgdorferi infection, treated with specific antimicrobial therapy and electrochemotherapy.
AuthorsAlessandro Gatti, Giuseppe Stinco, Sara Trevisini, Nicola di Meo, Diego Signoretto, Eugenio Leonardo, Serena Bonin, Giusto Trevisan
JournalDermatologic therapy (Dermatol Ther) 2014 Jul-Aug Vol. 27 Issue 4 Pg. 244-7 ISSN: 1529-8019 [Electronic] United States
PMID24754311 (Publication Type: Case Reports, Journal Article)
Copyright© 2014 Wiley Periodicals, Inc.
Chemical References
  • Anti-Bacterial Agents
Topics
  • Adult
  • Anti-Bacterial Agents (therapeutic use)
  • Borrelia Infections (drug therapy, pathology)
  • Borrelia burgdorferi (isolation & purification)
  • Electrochemotherapy (methods)
  • Female
  • Humans
  • Lymphoma, B-Cell, Marginal Zone (drug therapy, microbiology, pathology)
  • Male
  • Middle Aged
  • Skin Neoplasms (drug therapy, microbiology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: